Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Aug 2, 2020
Date Accepted: Oct 22, 2020
Date Submitted to PubMed: Oct 23, 2020

The final, peer-reviewed published version of this preprint can be found here:

Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial

O'Connor-Reina C, Ignacio-Garcia JM, Rodriguez-Ruiz E, Morillo Dominguez MDC, Ignacio Barrios V, Baptista Jardin P, Casado Morente JC, Garcia Iriarte MT, Plaza G

Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial

JMIR Mhealth Uhealth 2020;8(11):e23123

DOI: 10.2196/23123

PMID: 33093013

PMCID: 7683258

Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: A Pilot Randomized Controlled Trial

  • Carlos O'Connor-Reina; 
  • Jose Maria Ignacio-Garcia; 
  • Elisa Rodriguez-Ruiz; 
  • Maria Del Carmen Morillo Dominguez; 
  • Victoria Ignacio Barrios; 
  • Peter Baptista Jardin; 
  • Juan Carlos Casado Morente; 
  • Maria Teresa Garcia Iriarte; 
  • Guillermo Plaza

ABSTRACT

Background:

Background:

Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea–hypopnea syndrome (OSAHS) to perform oropharyngeal exercises.

Objective:

To examine the effects of the app in patients with severe OSAHS.

Methods:

Forty patients with severe OSAHS (apnea–hypoxia index [AHI] >30) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. Anthropometric measures, Epworth Sleepiness Scale (0-24), Pittsburgh Sleep Quality Index (0-21), and Iowa Oral Performance Instrument (IOPI) scores, and oxygen desaturation index were obtained before and after the intervention.

Results:

After the intervention, 28 patients remained. No significant changes were observed in the control group. The intervention group showed significant improvements. AHI decreased 53.4% from 44.7 (range 33.8-55.6) to 20.88 (14.02-27.7) events/h (P<.001). Oxygen desaturation index decreased 46.5% from 36.31 (27.19-43.43) to 19.4 (12.9-25.98) events/h (P=.003). IOPI maximum tongue score increased from 39.83 (35.32-45.20) to 59.06 (54.74-64.00) kPa (P<.001). IOPI maximum lip score increased from 27.89 (24.16-32.47) to 44.11 (39.5-48.80) kPa (P<.001). The AHI correlated significantly with IOPI tongue and lip improvements (Pearson coefficient −0.560, P<.001, and −0.460, P<.001, respectively).

Conclusions:

Orofacial exercises performed using an mHealth app reduce OSAHS severity and symptoms, and represent a promising treatment for OSAHS. Clinical Trial: Spanish Gov AWGAPN-2019-01; ClinicalTrials.gov NCT04438785.


 Citation

Please cite as:

O'Connor-Reina C, Ignacio-Garcia JM, Rodriguez-Ruiz E, Morillo Dominguez MDC, Ignacio Barrios V, Baptista Jardin P, Casado Morente JC, Garcia Iriarte MT, Plaza G

Myofunctional Therapy App for Severe Apnea–Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial

JMIR Mhealth Uhealth 2020;8(11):e23123

DOI: 10.2196/23123

PMID: 33093013

PMCID: 7683258

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.